World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
80
Citations
28577
World Ranking
16972
National Ranking
8512

Karen R. Cleary publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Karen R. Cleary sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 178 publications — 1st percentile

1% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Karen R. Cleary D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Karen R. Cleary sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 80 D-Index — 16th percentile

16% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Karen R. Cleary is affiliated with The University of Texas MD Anderson Cancer Center in the United States. Their research primarily focuses on medical and health professions fields, with specific expertise in emergency medical services, surgery, and pulmonary and respiratory medicine.

Their scholarly work addresses key topics related to central venous catheters and hemodialysis, vascular malformations and hemangiomas, and vascular procedures and complications.

One of their recent papers is titled "3:00 PM Abstract No. 156 Computer-assisted needle navigation for pediatric central venous cannulation: a feasibility study," published in 2020 in the Journal of Vascular and Interventional Radiology.

  • 3:00 PM Abstract No. 156 Computer-assisted needle navigation for pediatric central venous cannulation: a feasibility study (2020, Journal of Vascular and Interventional Radiology)

The publication venue for this work is the Journal of Vascular and Interventional Radiology, which is the frequent venue for their research output.

Their collaborative network includes coauthors such as C. Gallo, Pezhman Foroughi, Elisabeth Meagher, Ranjith Vellody, and Bhupender Yadav, each contributing to joint publications.

  • C. Gallo
  • Pezhman Foroughi
  • Elisabeth Meagher
  • Ranjith Vellody
  • Bhupender Yadav

Best Publications

  • Mutations in the p53 gene occur in diverse human tumour types

    J M Nigro;S J Baker;A C Preisinger;J M Jessup

  • Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer.

    Yutaka Takahashi;Yasuhiko Kitadai;Corazon D. Bucana;Karen R. Cleary

  • bcl-2 and p53 Oncoprotein Expression during Colorectal Tumorigenesis

    F. A. Sinicrope;San Bao Ruan;K. R. Cleary;L. C. Stephens

  • The Nuclear Factor-κB RelA Transcription Factor Is Constitutively Activated in Human Pancreatic Adenocarcinoma Cells

    Weixin Wang;James L. Abbruzzese;Douglas B. Evans;Lillie Larry

  • Simplified Staging for Hepatocellular Carcinoma

    Jean Nicolas Vauthey;Gregory Y. Lauwers;Nestor F. Esnaola;Kim Anh Do

  • Preoperative Gemcitabine-Based Chemoradiation for Patients With Resectable Adenocarcinoma of the Pancreatic Head

    Douglas B. Evans;Gauri R. Varadhachary;Christopher H. Crane;Charlotte C. Sun

  • Preoperative chemoradiation and pancreaticoduodenectomy for adenocarcinoma of the pancreas.

    Douglas B. Evans;Tyvin A. Rich;David R. Byrd;Karen R. Cleary

  • Preoperative and postoperative chemoradiation strategies in patients treated with pancreaticoduodenectomy for adenocarcinoma of the pancreas.

    F. R. Spitz;J. L. Abbruzzese;Jeffrey E Lee;Peter W Pisters

  • Tumor downstaging and sphincter preservation with preoperative chemoradiation in locally advanced rectal cancer: the M. D. Anderson Cancer Center experience

    Nora A Janjan;Vincent S Khoo;James Abbruzzese;Richard Pazdur

  • Rationale for En Bloc Vein Resection in the Treatment of Pancreatic Adenocarcinoma Adherent to the Superior Mesenteric-Portal Vein Confluence

    George M. Fuhrman;Steven D. Leach;Charles A. Staley;James C. Cusack

  • Vessel Counts and Expression of Vascular Endothelial Growth Factor as Prognostic Factors in Node-Negative Colon Cancer

    Yutaka Takahashi;Susan L. Tucker;Yasuhiko Kitadai;Aaryan N. Koura

  • Neoadjuvant chemoradiotherapy for adenocarcinoma of the pancreas: treatment variables and survival duration.

    T. M. Breslin;K. R. Hess;D. B. Harbison;M. E. Jean

  • Overexpression of oncogenic STK15/BTAK/Aurora A kinase in human pancreatic cancer.

    Donghui Li;Jijiang Zhu;Pervez F. Firozi;James L. Abbruzzese

  • MUC1 mucin expression as a marker of progression and metastasis of human colorectal carcinoma

    Shoji Nakamori;David M. Ota;Karen R. Cleary;Keiro Shirotani

  • Survival following pancreaticoduodenectomy with resection of the superior mesenteric–portal vein confluence for adenocarcinoma of the pancreatic head

    S. D. Leach;J. E. Lee;C. Charnsangavej;K. R. Cleary

  • p53 gene mutations in Barrett's epithelium and esophageal cancer.

    Alan G. Casson;Tapas Mukhopadhyay;Karen R. Cleary;Jae Y. Ro

  • Preoperative infusional chemoradiation therapy for stage T3 rectal cancer

    Tyvin A. Rich;John M. Skibber;Jaffer A. Ajani;Daniel J. Buchholz

  • Daclizumab, a humanized anti-interleukin-2 receptor alpha chain antibody, for treatment of acute graft-versus-host disease

    D. Przepiorka;N. A. Kernan;C. Ippoliti;E. B. Papadopoulos

  • Platelet-Derived Endothelial Cell Growth Factor in Human Colon Cancer Angiogenesis: Role of Infiltrating Cells

    Yutaka Takahashi;Corazon D. Bucana;Wenbiao Liu;Junya Yoneda

  • Improved overall survival among responders to preoperative chemoradiation for locally advanced rectal cancer.

    Nora A. Janjan;Christopher Crane;Barry W. Feig;Karen Cleary

Frequent Co-Authors

Douglas B. Evans
Douglas B. Evans Medical College of Wisconsin
James L. Abbruzzese
James L. Abbruzzese Duke University
Lee M. Ellis
Lee M. Ellis The University of Texas MD Anderson Cancer Center
John M. Skibber
John M. Skibber The University of Texas MD Anderson Cancer Center
Robert A. Wolff
Robert A. Wolff The University of Texas MD Anderson Cancer Center
Donna Przepiorka
Donna Przepiorka US Food and Drug Administration
Jeffrey E. Lee
Jeffrey E. Lee The University of Texas MD Anderson Cancer Center
Barry W. Feig
Barry W. Feig The University of Texas MD Anderson Cancer Center
Peter W.T. Pisters
Peter W.T. Pisters The University of Texas MD Anderson Cancer Center
Corazon D. Bucana
Corazon D. Bucana The University of Texas MD Anderson Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Considering a career in medicine opens up a wide variety of online degree options and pathways, many of which offer flexibility for working professionals or those looking to switch careers. One popular field is healthcare management; pursuing a healthcare administration online degree can lead to leadership roles in hospitals, clinics, and other medical settings.

If you are already a registered nurse, you might explore adn to fnp programs, which provide a bridge to advanced practice and family nurse practitioner roles. For those interested in nutrition and wellness, earning the best online food science degree can open up opportunities in dietetics, research, or food safety industries.

Pursuing advanced administration? Consider enrolling in one of the best online mha programs to deepen your expertise in health administration and policy. These online pathways support diverse interests and career goals within the expanding field of medicine.

Best Scientists Citing Karen R. Cleary

Recently Published Articles